Leading Blog

NOVEMBER 15, 2024

New technologies, shifting regulations, and a heightened focus on biotechnology and pharmaceuticals meant that professionals needed to stay ahead of the curve. We expanded our reach, developed new programs, and continued to evolve alongside the industry we served. Over the next eight years, Alkemy Partners flourished.

Uncertainty 336

Uncertainty Biotechnology Industry Training 336

The Horizons Tracker

OCTOBER 21, 2021

The market for PlayStation2 games was chosen because the lack of self-publishing opportunities at the time meant that developers had to partner with publishers to get their games to market. Developers typically look for a couple of things when choosing a publishing partner. Power play. Making the trade-off. Securing help.

Entrepreneur 129

Entrepreneur Biotechnology Pharmaceuticals Marketing 129

First Friday Book Synopsis

MARCH 8, 2011

John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders. He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health.

Biotechnology 85

Biotechnology Pharmaceuticals Consultative Industry 85

The Horizons Tracker

NOVEMBER 29, 2023

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value.

Diversity 115

Diversity Innovation Biotechnology Short-term 115

Career Advancement

MAY 25, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. To thrive in this role, he needed to develop new skills for dealing with a never-ending stream of demands. His responsibilities and the number of decisions he had to make drastically increased.

Tips 156

Tips Biotechnology Objective Learning-by-Doing 156

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Are You Using Dialects To Develop Your Employees’ Skills? You’ll be glad you did.

Bureaucracy 232

Bureaucracy Compliance Learning-by-Doing Engineering 232

Strategy Driven

OCTOBER 19, 2024

In a rapidly evolving digital landscape, biotechnology companies face the challenge of making their websites stand out. Conclusion A standout website is a crucial differentiator in the competitive biotechnology field. A solid online presence is crucial for conveying the complexities of biotech innovations while attracting stakeholders.

Biotechnology 93

Biotechnology Storytelling Audience Core Competence 93

Career Advancement

SEPTEMBER 27, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. To thrive in this role, he needed to develop new skills for dealing with a never-ending stream of demands. His responsibilities and the number of decisions he had to make drastically increased.

Tips 120

Tips Biotechnology Objective Learning-by-Doing 120

Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. From computer hardware and software to technology service providers, app developers and data processing, the potential for growth is seemingly limitless.

Health Care 66

Health Care Biotechnology Energy Insurance 66

The Horizons Tracker

DECEMBER 30, 2019

Location has always been vital for startups, both in terms of providing ready access to human capital to help develop the startup’s proposition, but also to provide ready access to a local market to help develop momentum. This has prompted many of the fastest growing companies of our age to congregate in the same places.

Biotechnology 51

Biotechnology Human Capital Travel Entrepreneur 51

Tanveer Naseer

JUNE 2, 2015

Dan was the president of a biotechnology company where I served in my first middle management role.

Biotechnology 100

Biotechnology Learning-by-Doing Audience Middle Management 100

HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. At the time, Gomez commented, “It is a privilege for me to join an organization that is focused on developing transformative medicines to address major public healthcare challenges worldwide.” The Moderna Success Story. Moderna Inc.,

CFO 52

CFO Chief Financial Officer Due Diligence Biotechnology 52

The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. After a few experiments, they pronounced it ready to ship to customers, and did not need to go through a formal development process. I cringed when I heard the story.

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

Skip Prichard

JULY 22, 2019

Tesla’s genius and education led him to develop the foundations for electric induction motors, wireless telegraphy, radios, neon lamps, and remote control. When Edison developed a commercially viable light bulb, he was able to convince Morgan to advance him $30,000 for the Edison Electric Light Company. Championing change is hard.”

Innovation 84

Innovation Social Capital Reputation How To 84

CO2

DECEMBER 15, 2023

This connection is often the catalyst for the most profound growth and development in a leader’s journey. These studies provide empirical evidence on how executive coaching significantly impacts leadership development, performance, and organizational success. These research findings align perfectly with the ethos of CO2 Coaching.

Executive Coaching 78

Executive Coaching Execution Commitment Biotechnology 78

Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. Training and development programs almost universally focus factory-like on inputs and outputs — absorb curriculum, check a box; learn a skill, advance a rung; submit to assessment, fix a problem.

Development 21

Development Biotechnology CIO Short-term 21

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

OCTOBER 26, 2011

Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 15

Energy Finance IPO Biotechnology 15

Harvard Business Review

MARCH 17, 2014

Under the broad umbrella of impact investments lie myriad sectors, asset types, and investment products, most of which still need to be developed and understood. First, impact investing needs time to develop. Impact Investing in the Future: Developed clusters across the spectrum. sanitation, housing, mobile banking).

Development 11

Development Microfinance Biotechnology Exit Strategy 11

Harvard Business Review

JANUARY 5, 2012

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. IT is good for developing countries — it empowers people and improves their lives.

Information Technology 17

Information Technology Technology Information Trends 17

Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.

Globalization 15

Globalization Marketing Venture Capitalist Biotechnology 15

Harvard Business Review

JUNE 21, 2013

We also find that companies in developed areas plan to hire in other developed regions (e.g., North America in Western Europe and vice versa) and many countries in developing regions are moving into developed regions (e.g., Asia into North America). All this presents a special challenge for Western European companies.

Telecommunications 15

Telecommunications Health Care Talent Management Biotechnology 15

Harvard Business Review

MARCH 1, 2011

And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice. And biotechnology and medical devices are among the leading areas for venture capital funding. Fortunes have been made from implants, surgical instruments, and artificial products.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 14

Globalization Innovation Decentralization Chemicals 14

Harvard Business Review

MAY 28, 2013

In one of the most comprehensive global surveys of corporate directors to date, we found that they were very worried about developing and enacting strategic plans that will enable their organizations to succeed. We might expect the regions with the lowest overall averages to be those dominated by developing or emerging economies.

Talent Management 11

Talent Management Company Telecommunications Management 11

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. Too often, any thought of changing a culture, never mind rebuilding it, seems like a Sisyphean task; the weight of the status quo ultimately rolls back and crushes such efforts.

Company 13

Company Pharmaceuticals Biotechnology Short-term 13

Harvard Business Review

OCTOBER 1, 2014

With an eye towards broadening and amplifying this conversation, we have developed a Scale Up Declaration , which we offer as a rallying point for what the entrepreneurship discussion should focus on, and what it should aim to accomplish.

Entrepreneur 14

Entrepreneur Biotechnology Real Estate Innovation 14

Harvard Business Review

MARCH 5, 2012

Indian companies, for instance, are already doing quite well exporting services like software development, technical support, and back-office processing to America. This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. But let's not kid ourselves.

Health Care 13

Health Care Biotechnology Industry Policies 13

Harvard Business Review

MARCH 1, 2012

For example, in biotechnology, a field in which the U.S. start-ups from developing and using production innovations such as integrated design that could have cemented a U.S. The growth of CMOs in high-tech fields such as alternative energy and integrated photonics would be a significant boost to the U.S. advantage for years to come.

Contract Manufacturing 13

Contract Manufacturing Offshoring Supply Chain Biotechnology 13

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. In fact, she was not brought into the discussion until campaigns were far along in their development and it was too late for her to influence the marketing team’s decisions. Do You Really Need to Hold That Meeting? Elizabeth Grace Saunders.

Restructuring 16

Restructuring How To Compliance Biotechnology 16

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). Second, the world of start-ups is narrowly focused. That’s not to say big companies should go it alone.

Innovation 11

Innovation Venture Capitalist Company Supply Chain 11

Harvard Business Review

SEPTEMBER 21, 2018

Only 13% of directors in the energy and utilities industry consider innovation to be a major strategic challenge, but the swift growth of renewable energy companies and such developments as the use of drones for monitoring oil and gas production suggest that no industry is impervious to the forces of innovation.

Innovation 14

Innovation Short-term Telecommunications Long-term 14

Harvard Business Review

FEBRUARY 22, 2013

Your company has just developed an amazing new product. Years of development, energy, and, of course, money have gone into it. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. He developed the next generation form of Provigil prior to the patent expiration.

Products 8

Products Productivity Biotechnology IPO 8

Harvard Business Review

OCTOBER 22, 2013

Develop Creative Discontent. This industry is fueled by advances in chemistry and biotechnology that allow the use of pharmacological and cosmetic therapies in areas where, earlier, surgical intervention was needed. Once they find it, they work on finding radical ideas and developing business proposals for top executives to review.

Skills 10

Skills Power Six Sigma Disruptive Innovation 10

Harvard Business Review

JUNE 3, 2013

Many wonder why an academy company like P&G, historically known for developing talent, did not, or was not able to, promote a successor from within its ranks. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Where was its leadership bench?

Succession 9

Succession Telecommunications Biotechnology Real Estate 9

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

JUNE 4, 2018

” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” The talents of all are not being developed to their fullest, and many U.S. ” Unfortunately, this goal hasn’t been met. industries face acute skills shortages.

Education 9

Education Company Biotechnology Human Capital 9